Regulation of gene expression of murine MD-1 regulates subsequent T cell activation and cytokine production

Journal of Immunology

Volumn 165, Issue 4, 2000, Pages 1925-1932

  Gorczynski, R M ^a   Chen, Z ^a   Clark, D A ^a   Hu, J ^a   Yu, G ^a   Li, X ^a   Tsang, W ^a   Hadidi, S ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; DENDRITIC CELL; GENE EXPRESSION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0034663751     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.4.1925     Document Type: Article

References (34)

1. Comparative analysis of B7-1 and B7-2 costimulatory ligands: Expression and function
2. The tissue distribution of the B7-2 costimulator in mice: Abundant expression on dendritic cells in situ and during maturation in vitro
3. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
4. Heterogeneity in antigen processing by different types of antigen- presenting cells: Effect of cell culture on antigen processing ability
5. Prolongation of cardiac graft survival with anti-CD4Ig plus hCTLA4Ig in primates
6. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28
7. Mechanisms of disease: The role of T-cell costimulatory activation pathways in transplant rejection
8. Prevention of autoimmune recurrence and rejection by adenovirus- mediated CTLA4Ig gene transfer to the pancreatic graft in BB rat
9. Cardiac allograft tolerance induced by intra-arterial infusion of recombinant adenoviral CTLA4Ig
10. Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice
11. Cyclophosphamide, but not CTLA4Ig, prolongs survival of fetal pig islet grafts in anti-T cell monoclonal antibody-treated NOD mice
12. Comparative strategies to induce long-term graft acceptance in fully allogeneic renal versus cardiac allograft models by CD28-B7 T cell costimulatory blockade: Role of thymus and spleen
13. Specific manipulation of immunity to skin grafts bearing multiple minor histocompatibility differences
14. Prolongation of cat small bowel or renal allograft survival by pretransplant transfusion and/or by varying the route of allograft venous drainage
15. Increased expression of the novel molecule Ox-2 is involved in prolongation of murine renal allograft survival
16. Different reticular elements in rat lymphoid tissue identified by localization of Ia, Thy-1 and MRC OX-2 antigens
17. Anti-rat OX-2 blocks increased small intestinal transplant survival after portal vein immunization
18. An immunoadhesin incorporating the molecule OX-2 is a potent immunosuppressant that prolongs allo- and xenograft survival
19. Evidence that an OX-2 positive cell can inhibit the stimulation of type-1 cytokine production by bone-marrow-derived B7-B1 (and B7-2) positive dendritic cells
20. Functional skewing of bone marrow-derived dendritic cells by Th1- or Th2-inducing cytokines
21. The molecular mechanism of B cell activation by Toll-like receptor protein RP-105
22. Molecular cloning of human RPI05
23. Phylogenetic perspectives in innate immunity
24. Inhibition by a CD14 monoclonal antibody of lipopolysaccharide binding to murine macrophages
25. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
26. Preparation and functional properties of monoclonal antibodies to human, mouse and rat OX-2
27. Endothelin-1 and vascular complication in liver transplantation
28. Aging processes, DNA damage, and repair
29. Preparation of monoclonal antibodies
30. Mouse MD-1, a molecule that is physically associated with RP105 and positively regulates its expression
31. Potent and selective gene inhibition using antisense oligodeoxynucleotides
32. A serum resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA
33. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival
34. Regulatory roles for CD14 and phosphatidylinositol in the signaling via toll-like receptor 4-MD-2